These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8517715)

  • 1. Effects of probenecid on the pharmacokinetics of allopurinol riboside.
    Were JB; Shapiro TA
    Antimicrob Agents Chemother; 1993 May; 37(5):1193-6. PubMed ID: 8517715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and metabolism of allopurinol riboside.
    Shapiro TA; Were JB; Danso K; Nelson DJ; Desjardins RE; Pamplin CL
    Clin Pharmacol Ther; 1991 May; 49(5):506-14. PubMed ID: 2029827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of American cutaneous leishmaniasis with orally administered allopurinol riboside.
    Saenz RE; Paz HM; Johnson CM; Marr JJ; Nelson DJ; Pattishall KH; Rogers MD
    J Infect Dis; 1989 Jul; 160(1):153-8. PubMed ID: 2659681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxypurinol, allopurinol and allopurinol-1-riboside in plasma following an acute overdose of allopurinol in a patient with advanced chronic kidney disease.
    Kannangara DR; Roberts DM; Furlong TJ; Graham GG; Williams KM; Day RO
    Br J Clin Pharmacol; 2012 May; 73(5):828-9. PubMed ID: 22098112
    [No Abstract]   [Full Text] [Related]  

  • 5. An association study of ABCG2 rs2231142 on the concentrations of allopurinol and its metabolites.
    Pilon MO; Leclair G; Oussaïd E; St-Jean I; Jutras M; Gaulin MJ; Mongrain I; Busseuil D; Rouleau JL; Tardif JC; Dubé MP; de Denus S
    Clin Transl Sci; 2022 Aug; 15(8):2024-2034. PubMed ID: 35689378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative metabolism of a new antileishmanial agent, allopurinol riboside, in the parasite and the host cell.
    Nelson DJ; LaFon SW; Elion GB; Marr JJ; Berens RL
    Adv Exp Med Biol; 1979; 122B():7-12. PubMed ID: 546162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of pyrazolopyrimidine ribonucleosides against Trypanosoma cruzi: studies in vitro and in vivo with sensitive and resistant strains.
    Berens RL; Marr JJ; Looker DL; Nelson DJ; LaFon SW
    J Infect Dis; 1984 Oct; 150(4):602-8. PubMed ID: 6436394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibility testing of Naegleria fowleri to ketoconazole, BAYn7133, and allopurinol riboside.
    Smego RA; Durack DT
    J Parasitol; 1984 Apr; 70(2):317-8. PubMed ID: 6088750
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of purine nucleoside phosphorylase activity and of T-cell function with allopurinol-riboside.
    Nishida Y; Kamatani N; Tanimoto K; Akaoka I
    Agents Actions; 1979 Dec; 9(5-6):549-52. PubMed ID: 121041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in healthy subjects.
    Stocker SL; Williams KM; McLachlan AJ; Graham GG; Day RO
    Clin Pharmacokinet; 2008; 47(2):111-8. PubMed ID: 18193917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of probenecid on the pharmacokinetics of mizoribine and co-administration of the two drugs in patients with nephrotic syndrome.
    Utsunomiya Y; Hara Y; Ito H; Okonogi H; Miyazaki Y; Hashimoto Y; Hosoya T
    Int J Clin Pharmacol Ther; 2010 Nov; 48(11):751-5. PubMed ID: 20979934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monophosphates of formycin B and allopurinol riboside. Interactions with leishmanial and mammalian succino-AMP synthetase and GMP reductase.
    Spector T; Jones TE; LaFon SW; Nelson DJ; Berens RL; Marr JJ
    Biochem Pharmacol; 1984 May; 33(10):1611-7. PubMed ID: 6732835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in patients with gout.
    Stocker SL; Graham GG; McLachlan AJ; Williams KM; Day RO
    J Rheumatol; 2011 May; 38(5):904-10. PubMed ID: 21285173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synergistic action of pyrazolopyrimidines and pentavalent antimony against Leishmania donovani and L. braziliensis.
    Martinez S; Looker DL; Berens RL; Marr JJ
    Am J Trop Med Hyg; 1988 Sep; 39(3):250-5. PubMed ID: 2845824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the metabolism of allopurinol. Formation of allopurinol-1-riboside in purine nucleoside phosphorylase deficiency.
    Reiter S; Simmonds HA; Webster DR; Watson AR
    Biochem Pharmacol; 1983 Jul; 32(14):2167-74. PubMed ID: 6409116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oxipurinol and allopurinol riboside on whewellite crystallization: in vitro and in vivo observations.
    Finlayson B; Burns J; Smith A; Du Bois L
    Invest Urol; 1979 Nov; 17(3):227-9. PubMed ID: 500322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of fosfomycin in normal and burn patients. Effect of probenecid.
    Potel G; Meignier M; Baron D; Reynaud A; Touze MD; Courtieu AL
    Drugs Exp Clin Res; 1989; 15(4):177-84. PubMed ID: 2776659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic interactions of cefprozil with food, propantheline, metoclopramide, and probenecid in healthy volunteers.
    Shukla UA; Pittman KA; Barbhaiya RH
    J Clin Pharmacol; 1992 Aug; 32(8):725-31. PubMed ID: 1487562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of allopurinol after single intravenous and oral doses. Noninteraction with benzbromarone and hydrochlorothiazide.
    Breithaupt B; Tittel M
    Eur J Clin Pharmacol; 1982; 22(1):77-84. PubMed ID: 7094977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of probenecid on the renal elimination of cimetidine.
    Gisclon LG; Boyd RA; Williams RL; Giacomini KM
    Clin Pharmacol Ther; 1989 Apr; 45(4):444-52. PubMed ID: 2702802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.